Comparison of NOM for ACLD Between Medical and Surgical Ward
Acute Left Colon Diverticulitis: is it Still a Surgical Disease When Only Medical Treatment is Required? A Retrospective Study Based on Propensity Score Matching
1 other identifier
observational
175
1 country
1
Brief Summary
In Europe, patients with acute left colon diverticulitis (ALCD) are usually admitted to surgical wards even when only medical treatment is required. The study compares ALCD non-operative management (NOM) between surgical and non-surgical environments regarding clinical outcomes, hospitalization length(LOS), and follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedApril 4, 2025
April 1, 2025
1.9 years
January 6, 2024
April 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospitalization length
Comparing patients with ACLD admitted for NOM to the surgical ward with those admitted to a non-surgical ward in terms of length of stay (LOS)
one month after admission
Secondary Outcomes (1)
Follow-up and recurrences
two years after the admission
Study Arms (2)
Surgical Group (SG)
Patients with ALCD undergoing NOM admitted to the surgical ward
Non-Surgical Group (NSG)
Patients with ALCD undergoing NOM admitted to the medical ward
Interventions
Non-operative management (NOM) for ALCD consists of lab test monitoring, fluid therapy, antibiotic therapy, abscess drainage if \>4cm, restoring a regular diet
Eligibility Criteria
Patients affected by ALCD
You may qualify if:
- patients affected by ALCD using a contrast-enhanced CT scan at admission undergoing NOM
You may not qualify if:
- immediate indication for surgery (i.e. patients with Hinchey III or IV ALCD or septic patients with Hinchey II)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manuela Mastronardi
Trieste, TS, 34149, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 6, 2024
First Posted
February 20, 2024
Study Start
January 1, 2024
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
April 4, 2025
Record last verified: 2025-04